lon:csrt
|
9602891
|
Apr 14th, 2024 12:00AM
|
Consort Medical Plc
|
2.0K
|
7.00
|
Open
|
|
Apr 14th, 2024 06:33AM
|
Apr 14th, 2024 06:33AM
|
Bringing Aesica together with Bespak within the Consort Medical group builds on Bespak’s rich drug delivery device heritage over the last 50 years and Aesica’s decade-long expansion into a leading European pharmaceutical CDMO. Today, Consort Medical is a leading, global, single source drug and delivery device CDMO. Optimising world-class drug delivery device development and manufacture, together with API and finished dose drug formulation and manufacture, within the same group streamlines and accelerates our pharmaceutical customers’ drug route to market. Consort Medical remains at the leading edge of innovation and is committed to investing in patient- and customer-driven innovation with the potential to create new treatments, new markets and new opportunities.
|
Open
|
|
Open
|
Consort Medical Plc
|
Hemel Hempstead
|
|
GB
|
HP2 4TZ
|
|
Consort Medical
|
|
|
lon:csrt
|
9602891
|
Apr 13th, 2024 12:00AM
|
Consort Medical Plc
|
2.0K
|
7.00
|
Open
|
|
Apr 13th, 2024 05:26AM
|
Apr 13th, 2024 05:27PM
|
Bringing Aesica together with Bespak within the Consort Medical group builds on Bespak’s rich drug delivery device heritage over the last 50 years and Aesica’s decade-long expansion into a leading European pharmaceutical CDMO. Today, Consort Medical is a leading, global, single source drug and delivery device CDMO. Optimising world-class drug delivery device development and manufacture, together with API and finished dose drug formulation and manufacture, within the same group streamlines and accelerates our pharmaceutical customers’ drug route to market. Consort Medical remains at the leading edge of innovation and is committed to investing in patient- and customer-driven innovation with the potential to create new treatments, new markets and new opportunities.
|
Open
|
|
Open
|
Consort Medical Plc
|
Hemel Hempstead
|
|
GB
|
HP2 4TZ
|
|
Consort Medical
|
|
|
lon:csrt
|
9602891
|
Apr 12th, 2024 12:00AM
|
Consort Medical Plc
|
2.0K
|
7.00
|
Open
|
|
Apr 12th, 2024 05:40AM
|
Apr 12th, 2024 02:36PM
|
Bringing Aesica together with Bespak within the Consort Medical group builds on Bespak’s rich drug delivery device heritage over the last 50 years and Aesica’s decade-long expansion into a leading European pharmaceutical CDMO. Today, Consort Medical is a leading, global, single source drug and delivery device CDMO. Optimising world-class drug delivery device development and manufacture, together with API and finished dose drug formulation and manufacture, within the same group streamlines and accelerates our pharmaceutical customers’ drug route to market. Consort Medical remains at the leading edge of innovation and is committed to investing in patient- and customer-driven innovation with the potential to create new treatments, new markets and new opportunities.
|
Open
|
|
Open
|
Consort Medical Plc
|
Hemel Hempstead
|
|
GB
|
HP2 4TZ
|
|
Consort Medical
|
|
|
lon:csrt
|
9602891
|
Apr 11th, 2024 12:00AM
|
Consort Medical Plc
|
2.0K
|
7.00
|
Open
|
|
Apr 11th, 2024 07:42AM
|
Apr 11th, 2024 05:32PM
|
Bringing Aesica together with Bespak within the Consort Medical group builds on Bespak’s rich drug delivery device heritage over the last 50 years and Aesica’s decade-long expansion into a leading European pharmaceutical CDMO. Today, Consort Medical is a leading, global, single source drug and delivery device CDMO. Optimising world-class drug delivery device development and manufacture, together with API and finished dose drug formulation and manufacture, within the same group streamlines and accelerates our pharmaceutical customers’ drug route to market. Consort Medical remains at the leading edge of innovation and is committed to investing in patient- and customer-driven innovation with the potential to create new treatments, new markets and new opportunities.
|
Open
|
|
Open
|
Consort Medical Plc
|
Hemel Hempstead
|
|
GB
|
HP2 4TZ
|
|
Consort Medical
|
|
|
lon:csrt
|
9602891
|
Apr 10th, 2024 12:00AM
|
Consort Medical Plc
|
2.0K
|
7.00
|
Open
|
|
Apr 10th, 2024 05:27AM
|
Apr 11th, 2024 12:57AM
|
Bringing Aesica together with Bespak within the Consort Medical group builds on Bespak’s rich drug delivery device heritage over the last 50 years and Aesica’s decade-long expansion into a leading European pharmaceutical CDMO. Today, Consort Medical is a leading, global, single source drug and delivery device CDMO. Optimising world-class drug delivery device development and manufacture, together with API and finished dose drug formulation and manufacture, within the same group streamlines and accelerates our pharmaceutical customers’ drug route to market. Consort Medical remains at the leading edge of innovation and is committed to investing in patient- and customer-driven innovation with the potential to create new treatments, new markets and new opportunities.
|
Open
|
|
Open
|
Consort Medical Plc
|
Hemel Hempstead
|
|
GB
|
HP2 4TZ
|
|
Consort Medical
|
|
|
lon:csrt
|
9602891
|
Apr 9th, 2024 12:00AM
|
Consort Medical Plc
|
2.0K
|
7.00
|
Open
|
|
Apr 9th, 2024 05:50AM
|
Apr 9th, 2024 03:59PM
|
Bringing Aesica together with Bespak within the Consort Medical group builds on Bespak’s rich drug delivery device heritage over the last 50 years and Aesica’s decade-long expansion into a leading European pharmaceutical CDMO. Today, Consort Medical is a leading, global, single source drug and delivery device CDMO. Optimising world-class drug delivery device development and manufacture, together with API and finished dose drug formulation and manufacture, within the same group streamlines and accelerates our pharmaceutical customers’ drug route to market. Consort Medical remains at the leading edge of innovation and is committed to investing in patient- and customer-driven innovation with the potential to create new treatments, new markets and new opportunities.
|
Open
|
|
Open
|
Consort Medical Plc
|
Hemel Hempstead
|
|
GB
|
HP2 4TZ
|
|
Consort Medical
|
|
|
lon:csrt
|
9602891
|
Apr 8th, 2024 12:00AM
|
Consort Medical Plc
|
2.0K
|
7.00
|
Open
|
|
Apr 8th, 2024 06:22AM
|
Apr 8th, 2024 06:22AM
|
Bringing Aesica together with Bespak within the Consort Medical group builds on Bespak’s rich drug delivery device heritage over the last 50 years and Aesica’s decade-long expansion into a leading European pharmaceutical CDMO. Today, Consort Medical is a leading, global, single source drug and delivery device CDMO. Optimising world-class drug delivery device development and manufacture, together with API and finished dose drug formulation and manufacture, within the same group streamlines and accelerates our pharmaceutical customers’ drug route to market. Consort Medical remains at the leading edge of innovation and is committed to investing in patient- and customer-driven innovation with the potential to create new treatments, new markets and new opportunities.
|
Open
|
|
Open
|
Consort Medical Plc
|
Hemel Hempstead
|
|
GB
|
HP2 4TZ
|
|
Consort Medical
|
|
|
lon:csrt
|
9602891
|
Apr 7th, 2024 12:00AM
|
Consort Medical Plc
|
2.0K
|
7.00
|
Open
|
|
Apr 7th, 2024 05:57AM
|
Apr 7th, 2024 09:27PM
|
Bringing Aesica together with Bespak within the Consort Medical group builds on Bespak’s rich drug delivery device heritage over the last 50 years and Aesica’s decade-long expansion into a leading European pharmaceutical CDMO. Today, Consort Medical is a leading, global, single source drug and delivery device CDMO. Optimising world-class drug delivery device development and manufacture, together with API and finished dose drug formulation and manufacture, within the same group streamlines and accelerates our pharmaceutical customers’ drug route to market. Consort Medical remains at the leading edge of innovation and is committed to investing in patient- and customer-driven innovation with the potential to create new treatments, new markets and new opportunities.
|
Open
|
|
Open
|
Consort Medical Plc
|
Hemel Hempstead
|
|
GB
|
HP2 4TZ
|
|
Consort Medical
|
|
|
lon:csrt
|
9602891
|
Apr 7th, 2024 12:00AM
|
Consort Medical Plc
|
2.0K
|
7.00
|
Open
|
|
Apr 7th, 2024 05:57AM
|
Apr 7th, 2024 05:57AM
|
Bringing Aesica together with Bespak within the Consort Medical group builds on Bespak’s rich drug delivery device heritage over the last 50 years and Aesica’s decade-long expansion into a leading European pharmaceutical CDMO. Today, Consort Medical is a leading, global, single source drug and delivery device CDMO. Optimising world-class drug delivery device development and manufacture, together with API and finished dose drug formulation and manufacture, within the same group streamlines and accelerates our pharmaceutical customers’ drug route to market. Consort Medical remains at the leading edge of innovation and is committed to investing in patient- and customer-driven innovation with the potential to create new treatments, new markets and new opportunities.
|
Open
|
|
Open
|
Consort Medical Plc
|
Hemel Hempstead
|
|
GB
|
HP2 4TZ
|
|
Consort Medical
|
|
|
lon:csrt
|
9602891
|
Apr 6th, 2024 12:00AM
|
Consort Medical Plc
|
2.0K
|
7.00
|
Open
|
|
Apr 6th, 2024 05:38AM
|
Apr 6th, 2024 05:38AM
|
Bringing Aesica together with Bespak within the Consort Medical group builds on Bespak’s rich drug delivery device heritage over the last 50 years and Aesica’s decade-long expansion into a leading European pharmaceutical CDMO. Today, Consort Medical is a leading, global, single source drug and delivery device CDMO. Optimising world-class drug delivery device development and manufacture, together with API and finished dose drug formulation and manufacture, within the same group streamlines and accelerates our pharmaceutical customers’ drug route to market. Consort Medical remains at the leading edge of innovation and is committed to investing in patient- and customer-driven innovation with the potential to create new treatments, new markets and new opportunities.
|
Open
|
|
Open
|
Consort Medical Plc
|
Hemel Hempstead
|
|
GB
|
HP2 4TZ
|
|
Consort Medical
|
|
|